摘要
１９８３年６月至１９９１年１２月，手术治疗原发性肺腺癌１１５例，占同期肺癌手术２７．３％。术后１、３、５年生存率分别为６７．０％、３５．４％、２１．８％，无手术死亡。本病发生率日趋上升，误诊率高达６７．８％；根治性手术是重要治疗手段，但不能控制潜在性微转移灶。作者就其独特临床特点、影响疗效因素、Ｎ_２淋巴结清除以及全身综合治疗等有关问题进行讨论。
From June 1983 to October 1991,115 patients with primary pulmonary adenocarcinoma were surgically treated in our unit. This series comprised 27.3%of the total number of lung cancer patients operated on during the same period of time.In follow-up period,the 1,3,5-year survival rates showed 67.0%,35.4%and 21.8%respectively. There was no operative mortality.The analysis demonstrated a tendency of gradual increase in the incidence of pulmonary adenocarcioma. The rate of misdiagnosis of this disease was 67.8%. Radical surgical therapy is the main procedure of choice but it can not control the latent micro-metastatic foci.The clinical characteristics of pulmonary adenocarcinoma,factors influencing the effectiveness of surgical treatment,resection including N2 lymph nodes and comprehensive adjuvant general therapy were emphatically discussed.
出处
《中华胸心血管外科杂志》
CSCD
北大核心
1995年第6期339-341,共3页
Chinese Journal of Thoracic and Cardiovascular Surgery
关键词
肺肿瘤
腺癌
外科手术
Lung cancer
Adenocarcinoma
Curativeeffect
